Metabolic-bariatric surgery (MBS) appears to lower the risk for pancreatic cancer in people with obesity, with a potentially greater effect in those who also have type 2 diabetes (T2D), new research suggests. In a meta-analysis of more than 3.7 million adults with obesity, those who had undergone MBS had less than half the risk for …
